The Lancet Regional Health. Western Pacific (Apr 2023)
Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
- Xiaosu Chen,
- Yanli Xu,
- Yan Xie,
- Weiliang Song,
- Ye Hu,
- Ayijiang Yisimayi,
- Sijie Yang,
- Fei Shao,
- Li Geng,
- Ying Wang,
- Hongmei Gao,
- Yansong Shi,
- Shuo Zhang,
- Ronghua Jin,
- Zhongyang Shen,
- Yunlong Cao
Affiliations
- Xiaosu Chen
- Frontier Research Center for Cell Response, Institute of Immunology, College of Life Sciences, Nankai University, Tianjin, PR China
- Yanli Xu
- Beijing Ditan Hospital, Capital Medical University, Beijing, PR China
- Yan Xie
- Department of Liver Transplantation, Tianjin Key Laboratory of Organ Transplantation, Tianjin First Central Hospital, Nankai University, Tianjin, PR China
- Weiliang Song
- Changping Laboratory, Beijing, PR China; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, PR China; School of Life Sciences, Peking University, Beijing, PR China
- Ye Hu
- Frontier Research Center for Cell Response, Institute of Immunology, College of Life Sciences, Nankai University, Tianjin, PR China
- Ayijiang Yisimayi
- Changping Laboratory, Beijing, PR China; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, PR China; School of Life Sciences, Peking University, Beijing, PR China
- Sijie Yang
- Changping Laboratory, Beijing, PR China; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, PR China; Peking-Tsinghua Center for Life Sciences, Tsinghua University, Beijing, PR China
- Fei Shao
- Changping Laboratory, Beijing, PR China
- Li Geng
- Infection Management Office, Tianjin First Central Hospital, Nankai University, Tianjin, PR China
- Ying Wang
- Nursing Department, Tianjin First Central Hospital, Nankai University, Tianjin, PR China
- Hongmei Gao
- Intensive Care Unit, Emergency Medical Research Institute, Tianjin First Central Hospital, Nankai University, Tianjin, PR China
- Yansong Shi
- Frontier Research Center for Cell Response, Institute of Immunology, College of Life Sciences, Nankai University, Tianjin, PR China
- Shuo Zhang
- Department of Thoracic Surgery, The Fourth Hospital of Inner Mongolia, Hohhot, PR China
- Ronghua Jin
- Beijing Ditan Hospital, Capital Medical University, Beijing, PR China
- Zhongyang Shen
- Organ Transplant Center, NHC Key Laboratory for Critical Care Medicine, Tianjin First Central Hospital, Nankai University, Tianjin, PR China; Corresponding author.
- Yunlong Cao
- Changping Laboratory, Beijing, PR China; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, PR China; School of Life Sciences, Peking University, Beijing, PR China; Corresponding author.
- Journal volume & issue
-
Vol. 33
p. 100758